This is an archived article.

February 21, 2008

School of Pharmacy programs ranked best in the nation

Faculty, staff and programs of the UW School of Pharmacy made the school one of the best in the country in 2007.


UW School of Pharmacy medicinal chemistry and pharmaceutical sciences research programs were ranked “best in the nation” in terms of scholarly productivity in a survey reported in The Chronicle of Higher Education. More than 200 programs at top-tier institutions, from leading state universities to elite private and ivy-league schools, were reviewed.



Allan Rettie, professor and chair of medicinal chemistry, was the author of the central article in Molecular Interventions on “The Pharmacogenomics of Warfarin: Closing in on Personalized Medicine.”


Dave Veenstra, associate professor of pharmacy, Lou Garrison, professor of pharmacy, Scott Ramsey, adjunct associate professor of pharmacy and Beth Devine, research associate professor of pharmacy, each authored articles in the top 100 downloaded from the journal, Value in Health, since its inception in 1998.


Larry Bauer, professor of pharmacy, Phil Hansten, professor emeritus of pharmacy, John Horn, professor of pharmacy, and their former student Jennifer Lill, received the American Society of Health System Pharmacists Drug Therapy Research Award for their work on “Cyclosporine-Drug Interactions and the Influence of Age.”


Rene Levy, professor of pharmaceutics, was one of five UW faculty members to be elected as a fellow of the American Association for the Advancement of Science.


Peggy Odegard, associate professor of pharmacy, was named as a fellow of the American Society of Consultant Pharmacists.


Sid Nelson, dean of the School of Pharmacy, was named Outstanding Dean of the Year for 2007 by the American Pharmacists Association Academy of Student Pharmacists from a pool of nearly 100 pharmacy deans across the nation.


Lou Garrison, professor of pharmacy, has received a grant from The Bill & Melinda Gates Foundation in the amount of $550,000 to support an economic evaluation of potential innovations in measles vaccination in resource-limited settings.The nine-month project — The Global Measles Vaccination Strategies (GM-VIS) study – will examine the likely cost and health impacts of  innovations, such as improved thermostability or needle-free delivery. Co-investigators include Tom Hazlet, Srikanth Kadiyala, DaveVeenstra, and Brian Bresnahan, as well as Chris Bauch, an infectious disease modeler, from the Univesity of Guelph in Canada.


Students of the UW School of Pharmacy won two U.S. Department of Health and Human Services Health Resources and Services Administration awards in promoting health literacy.  


For more information about the UW School of Pharmacy, please contact Gail Viscione at viscione@u.washington.edu or 206-543-5002.